News & Updates
Showing Oncology articles
Showing

Concurrent H1 antihistamines associated with better survival in BCG-treated bladder cancer
Use of H1 antihistamines (H1-AH) during intravesical bacillus Calmette-Guérin (BCG) immunotherapy is associated with better overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and progression-free survival (PFS) in patients with non–muscle-invasive bladder cancer (NMIBC), according to a territory-wide retrospective observational study by researchers from the Chinese University of Hong Kong.
Concurrent H1 antihistamines associated with better survival in BCG-treated bladder cancer
21 Dec 2025
HPV vaccine uptake remains low in SG despite improved awareness
Knowledge of human papillomavirus (HPV) vaccination has improved in Singapore following government efforts to enhance cervical cancer awareness through national campaigns and policy changes. However, this has not translated to an increase in vaccine acceptance rates, according to a study.
HPV vaccine uptake remains low in SG despite improved awareness
18 Dec 2025
Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC
The combination of chemotherapy and anti-EGFR/BRAF therapy provides optimal survival benefits to patients with advanced BRAF-mutated colorectal cancer (CRC), according to a study.






